Helix BioMedix, Inc. (HXBM)

23.27 0.00 (0.00%) At close: 10:31AM EDT

Helix BioMedix, Inc.

22121-17th Avenue SE
Suite 112
Bothell, WA 98021
United States
425-402-8400
https://www.helixbiomedix.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 8

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Robin L. Carmichael	President, CEO & Director	304.35k	N/A	1957
Kelly Forsythe	Associate Director of Marketing	N/A	N/A	N/A

Amounts are as of 31 December 2011, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.

Corporate governance

Helix BioMedix, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.